High-dose therapy with autologous stem cell transplantation (ASCT) has been extensively used in the past 15 years in multiple myeloma. The IFM 90 trial has shown that autologous bone marrow transplantation (BMT) is superior to conventional chemotherapy in terms of response rate, event free survival,
β¦ LIBER β¦
Role of allogeneic stem cell transplantation in multiple myeloma
β Scribed by Shaji Kumar
- Book ID
- 107540207
- Publisher
- Current Science Inc.
- Year
- 2008
- Tongue
- English
- Weight
- 183 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1558-8211
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The role of stem cell transplantation in
β
Jean-Luc Harousseau; Michel Attal
π
Article
π
2002
π
Elsevier Science
π
English
β 193 KB
Role of autologous stem cell transplanta
β
Shaji Kumar
π
Article
π
2007
π
Current Science Inc.
π
English
β 389 KB
I04 Stem cell transplantation in multipl
β
G. Gahrton
π
Article
π
2007
π
Elsevier Science
π
English
β 59 KB
Predictors of prolonged survival after a
β
Qaiser Bashir; Hassan Khan; Robert Z. Orlowski; Ali Imran Amjad; Nina Shah; Simr
π
Article
π
2012
π
John Wiley and Sons
π
English
β 746 KB
## Abstract A total of 149 patients with multiple myeloma (MM) who received allogeneic hematopoietic stem cell transplantation (alloβHCT) with myeloablative (MAC; __n__ = 38) or reducedβintensity conditioning (RIC; __n__ = 110) regimens at MD Anderson Cancer Center were evaluated. Of the total, 120
Donor cell-derived acute lymphocytic leu
β
Natsue Igarashi; Takaaki Chou; Takayuki Hirose; Yousuke Imai; Takuro Ishiguro; K
π
Article
π
2009
π
Carden Jennings Publishing
π
English
β 227 KB
Current status of stem cell transplantat
β
Morie A. Gertz; Martha Q. Lacy; Angela Dispenzieri; Suzanne Hayman
π
Article
π
2005
π
Springer
π
English
β 428 KB